日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study

在 t(11;14) 阳性复发/难治性多发性骨髓瘤中,维奈托克-地塞米松与泊马度胺-地塞米松的疗效比较:随机 III 期 CANOVA 研究的主要结果

Popat, Rakesh; Beksac, Meral; Dimopoulos, Meletios A; Gatt, Moshe E; Gay, Francesca; Jo, Jae-Cheol; Kapoor, Prashant; Katodritou, Eirini; Kortüm, K Martin; Ling, Silvia; Nagarajan, Chandramouli; Suzuki, Kenshi; Qiu, Lugui; Onishi, Maika; Ku, Grace; Dail, Monique; Mukherjee, Nabanita; Ross, Jeremy A; Badawi, Mohamed Ali; Fusco, Mary Jean; Dobkowska, Edyta; Arriola, Emma; Bueno, Orlando F; Bahlis, Nizar J; Iida, Shinsuke; Moreau, Philippe; Valent, Jason; Mateos, María-Victoria

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy

接受抗BCMA嵌合抗原受体T细胞疗法的多发性骨髓瘤患者中病毒再激活

Cohen, Ido; Lebel, Eyal; Grisariu, Sigal; Avni, Batia; Kfir-Erenfeld, Shlomit; Asherie, Nathalie; Zimran, Eran; Vainstein, Vladimir; Assayag, Miri; Sharon, Tatyana Dubnikov; Alexander-Shani, Rivka; Bessig, Nomi; Shehadeh, Alaa; Ishtay, Aseel; Schlossberg, Miriam; Pick, Marjorie; Gatt, Moshe E; Bdolah-Abram, Tali; Stepensky, Polina; Elias, Shlomo

Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis

Talquetamab 可使既往接受过大量治疗的系统性轻链淀粉样变性患者产生深度缓解。

Shragai, Tamir; Ganayem, Muhammad; Cohen, Yael C; Avivi, Irit; Lebel, Eyal; Even-Gross Zohar, Noa; Melamed, Natan; Gatt, Moshe E

A phase 2 randomized study of modakafusp alfa as a single agent for patients with relapsed/refractory multiple myeloma

一项针对复发/难治性多发性骨髓瘤患者的莫达卡福斯普α单药治疗的II期随机研究

Holstein, Sarah A; Atrash, Shebli; Mian, Hira; Dimopoulos, Meletios A; Schjesvold, Fredrik; Popat, Rakesh; Shah, Nishi; Gatt, Moshe E; Gocke, Christian B; Frenzel, Laurent; Touzeau, Cyrille; Beksac, Meral; Manier, Salomon; Magen, Hila; Travis, Patrick; Nadeem, Omar; Suryanarayan, Kaveri; Li, Cheryl; Li, Shuli; Nelson, Allison; Cherepanov, Dasha; Parot, Xavier; Vogl, Dan T

High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T)

接受 B 细胞成熟抗原 (BCMA) 靶向嵌合抗原受体 T 细胞 (CAR-T) 治疗的患者中,细胞因子释放综合征相关凝血病发生率高,但出血和血栓形成发生率低。

Arad, Ariela; Katz, Maya; Lebel, Eyal; Kalish, Yosef; Assayag, Miri; Avni, Batia; Elias, Shlomo; Grisariu, Sigal; Shai, Ela; Kfir-Erenfeld, Shlomit; Asherie, Nathalie; Gatt, Moshe E; Stepensky, Polina; Zimran, Eran

Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with Pediatric-Inspired Protocols in Adolescent and Young Adults and Adult Patients with Acute Lymphoblastic Leukemia

预后因素、FLT-3 突变以及采用儿科方案治疗青少年、青年和成人急性淋巴细胞白血病患者的治疗结果

Gross Even Zohar, Noa; Oanunu, Uriel; Gross Even-Zohar, Noa; Aumann, Shlomzion; Vainstein, Vladimir; Gural, Alexander; Gatt, Moshe E; Haran, Arnon; Nachmias, Boaz

Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature

Belantamab Mafodotin治疗复发/难治性AL淀粉样变性:真实世界多中心经验及文献综述

Lebel, Eyal; Vainstein, Vladimir; Milani, Paolo; Palladini, Giovanni; Shragai, Tamir; Lavi, Noa; Magen, Hila; Assayag, Miri; Avivi, Irit; Gatt, Moshe E

Amyloidogenic light chains impair plasma cell survival

淀粉样变性轻链损害浆细胞存活

Marjorie Pick, Eyal Lebel, Sharona Elgavish, Hadar Benyamini, Yuval Nevo, Rachel Hertz, Jacob Bar-Tana, Paola Rognoni, Giampaolo Merlini, Moshe E Gatt

Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial

开发和生产新型本地生产的抗BCMA CAR-T细胞用于治疗复发/难治性多发性骨髓瘤:一项I期临床试验的结果

Asherie, Nathalie; Kfir-Erenfeld, Shlomit; Avni, Batia; Assayag, Miri; Dubnikov, Tatyana; Zalcman, Nomi; Lebel, Eyal; Zimran, Eran; Shaulov, Adir; Pick, Marjorie; Cohen, Yael; Avivi, Irit; Cohen, Cyrille; Gatt, Moshe E; Grisariu, Sigal; Stepensky, Polina

Do older patients truly benefit from advances in myeloma care?

老年患者真的能从多发性骨髓瘤治疗的进步中受益吗?

Gatt, Moshe E; Lebel, Eyal